Thomas Podsadecki
AbbVie (United States)(US)University of Florida(US)Columbus Oncology and Hematology Associates(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin(2014)901 cited
- → ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis(2014)874 cited
- → ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV(2014)691 cited
- → Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin(2014)515 cited
- → ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection(2014)367 cited
- → Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1(2015)305 cited